FDA Inspection
Solara Active Pharma Sciences LimitedSolara Active Pharma Sciences Limited – FDA Inspection, Feb 6, 2026
Record Details
This FDA Inspection record concerns Solara Active Pharma Sciences Limited, with an inspection on February 6, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 638e96e0-8a94-4b90-9028-62c172f06723
Inspection Facts
- Inspection number
- 1306762
- FDA center
- Human Drugs
Other FDA inspections of Solara Active Pharma Sciences Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| February 21, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 5, 2017 | Not classified | Office of Inspections and Investigations | |
| February 20, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 7, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 4, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Solara Active Pharma Sciences Limited
- FDA Inspection 1122187 - 2020-02-21
- FDA Inspection 1013838 - 2017-05-05
- FDA Inspection 921681 - 2015-02-20
- FDA Inspection 840149 - 2013-06-07
- FDA Inspection 754991 - 2011-11-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.